Recent Updates
Recently added Catalysts
BFLY Positive Sentiment

Merge Labs and Butterfly Network Partner to Advance Ultrasound-Based Brain-Computer Interfaces

Key Takeaway: Butterfly Network, Inc. and Merge Labs have entered a multi-year licensing agreement. This partnership allows Merge to utilize Butterfly's advanced Poseidon Family of Ultrasound-on-Chip technology. The focus will be on developing ultrasound-based brain-computer interfaces, showcasing a commitment to innovation in healthcare technology.

Market Sentiment Analysis

POSITIVE FACTORS

  • Partnership aims to advance innovative brain-computer interfaces.
  • Access to advanced ultrasound technology enhances development capabilities.
  • Collaboration reflects commitment to integrating AI in healthcare.

Full Press Release Details

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. ("Butterfly") (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound, programmable cloud software and AI, and Merge Labs today announced a multi-year licensing agreement through Butterfly Embedded™. The agreement gives Merge access to Butterfly’s Poseidon Family of Ultrasound-on-Chip™ technology for the development of ultrasound-based brain-computer interfaces (BCI). Merge Labs was founded with the long-term mi

Frequently Asked Questions

What is the purpose of the partnership between Butterfly and Merge Labs?

The partnership aims to develop ultrasound-based brain-computer interfaces.

What technology will Merge Labs access through this agreement?

Merge Labs will access Butterfly's Poseidon Family of Ultrasound-on-Chip technology.

How long is the licensing agreement between the two companies?

The agreement is a multi-year licensing deal.

What is Butterfly Network known for?

Butterfly Network is a leader in semiconductor-based ultrasound and AI technology.

Last updated: Sep 1, 2026